Thomas J. Herzfeld Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Thomas J. Herzfeld Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $4,154 - $5,066	6 New	6 $4.94 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $700 - $830	-1 Reduced 12.5%	7 $5,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $472 - $558	1 Added 14.29%	8 $4,000
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $3,453 - $4,507	7 New	7 $4,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.